Skip to main content

Table 1 MR estimates from different methods of assessing the causal effect of IBD on BMDs

From: Mendelian randomization study of inflammatory bowel disease and bone mineral density

BMDs

Step#

No. of SNP

IVW

MBE

WMM

MR-Egger

MR.RAPS

β (95%CI)

P value

Cochran Q statistics (df)

P value

β (95%CI)

P value

β (95%CI)

P value

Slope (95%CI)

P value

Intercept (Se)

P value

Cochran Q statistics (df)

P value

β (95%CI)

P value

IBD and TB-BMD

3

119

− 0.017 (− 0.029, − 0.0046)

0.0067

146.2 (118)

0.040

− 0.0054 (− 0.031, 0.020)

0.67

− 0.0059 (− 0.024, 0.013)

0.53

− 0.016 (− 0.045, 0.013)

0.29

− 9.89e−5 (0.0016)

0.95

146.20 (117)

0.035

− 0.016 (− 0.028, − 0.0028)

0.017

IBD and FN-BMD

3

118

− 0.019 (− 0.035, − 0.0032)

0.018

140.57 (117)

0.068

− 0.049 (− 0.084, − 0.013)

0.0079

− 0.024 (− 0.047, − 0.00035)

0.047

− 0.0025 (− 0.039, 0.034)

0.90

− 0.0020 (0.0020)

0.33

139.42 (116)

0.068

− 0.018 (− 0.034, − 0.0014)

0.034

IBD and LS-BMD

3

120

− 0.012 (− 0.030, 0.0053)

0.17

135.03 (119)

0.15

− 0.034 (− 0.070, 0.0023)

0.069

− 0.029 (− 0.056, − 0.0018)

0.037

− 0.015 (− 0.057, 0.027)

0.48

0.00032 (0.0023)

0.89

125.00 (118)

0.14

− 0.013 (− 0.032, 0.0047)

0.15

IBD and FA-BMD

3

124

− 0.026 (− 0.057, 0.0058)

0.11

142.47 (123)

0.11

− 0.015 (− 0.084, 0.055)

0.68

− 0.017 (− 0.064, 0.029)

0.46

0.012 (− 0.063, 0.086)

0.76

− 0.0044 (0.0041)

0.29

141.14 (122)

0.11

− 0.028 (− 0.060, 0.0049)

0.095

IBD and TB-BMD(R*)

3

102

− 0.016 (− 0.027, − 5.46e−3)

0.0033

102.48 (101)

0.44

− 0.012 (− 0.037, 1.28e−2)

0.35

− 0.012 (− 0.030, 5.82e−3)

0.19

− 0.026 (− 0.052, − 9.06e−5)

0.052

0.0012 (0.0015)

0.42

101.82 (100)

0.43

− 0.016 (− 0.027, − 4.39e−3)

0.0064

IBD and FN-BMD(R*)

3

100

− 0.014 (− 0.030, 0.0014)

0.074

113.58 (99)

0.15

− 0.042 (− 0.078, − 0.0054)

0.027

− 0.028 (− 0.051, − 0.0044)

0.020

− 0.022 (− 0.058, 0.015)

0.24

0.00094 (0.0021)

0.66

113.36 (98)

0.14

− 0.015 (− 0.032, 0.0021)

0.086

IBD and LS-BMD(R*)

3

101

0.00062 (− 0.018, 0.020)

0.95

122.96 (100)

0.059

− 0.021 (− 0.056, 0.015)

0.27

− 0.022 (− 0.051, 0.0076)

0.15

− 0.030 (− 0.073, 0.013)

0.18

0.0039 (0.0025)

0.13

120.13 (99)

0.073

0.0023 (− 0.018, 0.022)

0.82

IBD and FA-BMD(R*)

3

105

− 0.026 (− 0.058, 0.0049)

0.098

116.14 (104)

0.20

− 0.012 (− 0. 082, 0.058)

0.75

− 0.011 (− 0.059, 0.037)

0.65

− 0.0017 (− 0.076, 0.073)

0.96

− 0.0031 (0.0044)

0.48

115.56 (103)

0.19

− 0.028 (− 0.062, 0.0051)

0.097

  1. Step#: 3, MR analysis after removing all the SNPs (with P value less than 1 in MR-PRESSO outlier test); R*, in replication practice
  2. TB-BMD total body bone mineral density, FN-BMD femoral neck bone mineral density, LS-BMD lumbar spine bone mineral density, FA-BMD forearm bone mineral density, β beta coefficient, Se standard error, SNP single nucleotide polymorphism, MR Mendelian randomization, IVW inverse variance weighting, MR-PRESSO MR-Pleiotropy RESidual Sum and Outlier method, MBE mode-based estimate method, WMM weighted median method, MR.RAPS robust adjusted profile score